Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - India
Summary - Ixekizumab 80 Mg Inj , Toclizumab 162 Mg Per 0.9 Ml Pfs ,Botulinum Toxin Type A 200 Unit Inj , Inj Ocreluzumab 300Mg Per 10 Ml , Diazepam 10 Mg 2 Ml Inj , Inj Diltiazem 5Mgper Ml , Lignocaine Hcl Solution 2 Percent For Iv Use 50 Mlinj , Troponin T Test Card Quantity: 640
Deadline - login to view
GT reference number - 109722109
Product classification - Medicinal products for the alimentary tract and metabolism
Address - India
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 109722109
Document Type - Tender Notices
Description - notice_title: Ixekizumab 80 Mg Inj , Toclizumab 162 Mg Per 0.9 Ml Pfs ,Botulinum Toxin Type A 200 Unit Inj , Inj Ocreluzumab 300Mg Per 10 Ml , Diazepam 10 Mg 2 Ml Inj , Inj Diltiazem 5Mgper Ml , Lignocaine Hcl Solution 2 Percent For Iv Use 50 Mlinj , Troponin T Test Card Quantity: 640local title:: Ixekizumab 80 mg inj , Toclizumab 162 mg per 0.9 ml PFS ,Botulinum Toxin Type A 200 Unit inj , Inj Ocreluzumab 300mg per 10 ml , Diazepam 10 mg 2 ml inj , inj Diltiazem 5mgper ml , Lignocaine HCL solution 2 percent for IV use 50 mlinj , Troponin T Test card Quantity: 640 tender_quantity: 640
Gt Ref Id - 109722109
Deadline - Jun 17, 2025
Similar Tenders :
Summary:
|
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database